We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.1B
AUM Growth
+$312M
Cap. Flow
-$44.8M
Cap. Flow %
-0.37%
Top 10 Hldgs %
38.76%
Holding
1,279
New
83
Increased
328
Reduced
404
Closed
81

Sector Composition

Rank Sector Weight
1 Real Estate 72.69%
2 Technology 4.79%
3 Financials 3.72%
4 Healthcare 2.91%
5 Industrials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMAB icon
1101
Genmab
GMAB
$17.7B
$4K ﹤0.01%
+171
New +$3.73K
KURA icon
1102
Kura Oncology
KURA
$901M
$4K ﹤0.01%
288
NTLA icon
1103
Intellia Therapeutics
NTLA
$1.49B
$4K ﹤0.01%
288
OMER icon
1104
Omeros
OMER
$821M
$4K ﹤0.01%
309
PACB icon
1105
Pacific Biosciences
PACB
$422M
$4K ﹤0.01%
864
-96
-10% -$488
QTRX icon
1106
Quanterix
QTRX
$173M
$4K ﹤0.01%
158
-20
-11% -$456
TVTX icon
1107
Travere Therapeutics
TVTX
$5.27B
$4K ﹤0.01%
263
TWST icon
1108
Twist Bioscience
TWST
$5.39B
$4K ﹤0.01%
+186
New +$4.35K
TXMD icon
1109
TherapeuticsMD
TXMD
$24M
$4K ﹤0.01%
31
XBIT icon
1110
XBiotech
XBIT
$68.9M
$4K ﹤0.01%
+232
New +$2.99K
TECX
1111
Tectonic Therapeutic
TECX
$578M
$4K ﹤0.01%
15
-2
-12% -$386
TVRD
1112
Tvardi Therapeutics
TVRD
$23.8M
$4K ﹤0.01%
7
-1
-13% -$702
IMGN
1113
DELISTED
Immunogen Inc
IMGN
$4K ﹤0.01%
845
-110
-12% -$373
RUBY
1114
DELISTED
Rubius Therapeutics, Inc
RUBY
$4K ﹤0.01%
450
-53
-11% -$513
FLXN
1115
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4K ﹤0.01%
215
-28
-12% -$472
ACIU icon
1116
AC Immune
ACIU
$234M
$3K ﹤0.01%
425
ANAB icon
1117
AnaptysBio
ANAB
$1.59B
$3K ﹤0.01%
172
ARDX icon
1118
Ardelyx
ARDX
$1.25B
$3K ﹤0.01%
+355
New +$2.16K
ASMB icon
1119
Assembly Biosciences
ASMB
$513M
$3K ﹤0.01%
+12
New +$2.21K
BCRX icon
1120
BioCryst Pharmaceuticals
BCRX
$2.43B
$3K ﹤0.01%
869
+172
+25% +$433
CSTL icon
1121
Castle Biosciences
CSTL
$741M
$3K ﹤0.01%
+96
New +$2.35K
DNTH icon
1122
Dianthus Therapeutics
DNTH
$5.71B
$3K ﹤0.01%
14
MGNX icon
1123
MacroGenics
MGNX
$254M
$3K ﹤0.01%
310
PRTA icon
1124
Prothena Corp
PRTA
$455M
$3K ﹤0.01%
212
URGN icon
1125
UroGen Pharma
URGN
$2.02B
$3K ﹤0.01%
118
-15
-11% -$409

Similar funds

Daiwa Securities Group's Q4 2019 Portfolio in Review

As of Q4 2019, Daiwa Securities Group held 1,279 positions worth $12.1B, up 2.6% from $11.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group's Q4 2019 filing shows 83 new, 328 increased, 404 reduced and 81 closed positions. Its largest new stake was Performance Food Group: 109,263 shares worth $5.63M. The largest sale was Sun Communities, an estimated $208M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q4 2019 buy was Performance Food Group: 109,263 shares worth $5.63M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q4 2019, an estimated $239M increase.
  • Daiwa Securities Group's biggest Q4 2019 reduction was Sun Communities, cutting an estimated $208M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2019, selling an estimated $13.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $12.1B portfolio in Q4 2019.
  • Daiwa Securities Group opened 83 new positions and closed 81 in Q4 2019.
  • Daiwa Securities Group's portfolio value rose 2.6% quarter-over-quarter to $12.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.